<DOC>
	<DOCNO>NCT00100126</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety APC-231 QD 7 day bacteriological outcome Test Cure Visit .</brief_summary>
	<brief_title>APC-231 Once Day ( QD ) 7 Days v . Penicillin Taken Four Times Day ( QID ) Pediatric Patients With Strep Throat</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Give informed consent , assent , documentation patient authorization disclosure study result . Since patient legal age consent , assent patient must obtain ( applicable follow state regulation ) write informed consent obtain parent legal guardian . Age &gt; = 6 month 12 year . A clinical diagnosis acute tonsillitis and/or pharyngitis define clinical sign symptom compatible tonsillitis and/or pharyngitis , include sore throat difficulty feed swallow irritability suggest presence sore throat least one following : Tonsillar pharyngeal exudate Tender cervical lymph node Fever history fever treat antipyretic Odynophagia Uvular edema Pharyngeal Erythema moderate great intensity Elevated white blood cell ( WBC ) &gt; 12,000/mm3 10 % band Red tongue prominent papilla ( Strawberry tongue ) A positive rapid screen test S. pyogenes ( enzyme immunoassay ; SiGNIFY™ Strep A Test ) . Patient appropriate candidate oral antibiotic therapy swallow study dosage form . Females must nonlactating : If childbearing potential sexually active , patient must negative prestudy urine pregnancy test utilize acceptable birth control method throughout study . Chronic recurrent ( two week duration two time per year ) odynophagia enlarge tonsil secondary viral prove bacterial etiology . The need hospitalization I.V . antimicrobial therapy . Pharyngitis know suspect due pathogen resistant betalactam antimicrobial . Patients known carrier S. pyogenes . Previous allergy , serious adverse reaction , intolerance , penicillin member betalactam class antimicrobial . Any serious illness concomitant condition investigator judge would preclude study evaluation make unlikely course study therapy followup could complete . This would also include : Any rapidly progressive underlie disease shorten life expectancy . The inability swallow study dosage form . Unable understand requirement study . Neutropenia ( &lt; 1000 PMNs/mm3 ) know immunocompromised state . Hard chill rigor . Seizure disorder lower seizure threshold . This exclude child previous febrile seizure . Psychiatric condition require use major tranquilizer . Pregnancy nursing . Expectation additional effective systemic antibacterial would require condition duration study . Current drug alcohol abuse . Receipt experimental drug medical device within previous 30 day ( schedule receive experimental procedure study period ) . Previous treatment protocol . Systemic antimicrobial therapy benzathine penicillin within 30 day azithromycin within 14 day . Hospitalization within month prior study admission , antibacterial therapy administer . The presence clinically significant hematologic condition cardiac valvular disease . History cardiovascular disease , renal disease , neurological disease secondary previous infection S. pyogenes . Probenecid treatment systemic steroid duration study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Pharyngitis</keyword>
	<keyword>Strep throat</keyword>
</DOC>